Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$422M |
| 2 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$411M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$351M |
| 4 |
Pfizer
PFE
|
+$331M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.28B |
| 2 |
Meta Platforms (Facebook)
META
|
+$989M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$953M |
| 4 |
Amazon
AMZN
|
+$816M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$782M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.23% |
| 2 | Technology | 2.06% |
| 3 | Consumer Discretionary | 1.41% |
| 4 | Healthcare | 0.83% |
| 5 | Financials | 0.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11201
Wave Life Sciences
WVE
$1.02B
| $109K | ﹤0.01% |
21,558
-8,661
| -29% | -$46.3K |
|
11202
Annexon
ANNX
$995M
| $109K | ﹤0.01% |
23,945
-196,541
| -89% | -$486K |
|
11203
CALL
LanzaTech
LNZA
$81.4M
| $109K | ﹤0.01% |
+216
| New | +$95K |
|
|
LEO
11204
BNY Mellon Strategic Municipals
LEO
$384M
| $109K | ﹤0.01% |
18,525
-831
| -4% | -$4.57K |
|
11205
CALL
Worksport
WKSP
$9.64M
| $108K | ﹤0.01% |
7,280
-2,660
| -27% | -$42.2K |
|
11206
PUT
DocGo
DCGO
$41M
| $108K | ﹤0.01% |
19,400
-79,000
| -80% | -$454K |
|
11207
CALL
Ezcorp Inc
EZPW
$2.11B
| $108K | ﹤0.01% |
12,400
-166,300
| -93% | -$1.4M |
|
|
BNKK
11208
PUT
Bonk Inc
BNKK
$10.6M
| $108K | ﹤0.01% |
+877
| New | +$82.6K |
|
|
ARBK
11209
PUT
Argo Blockchain
ARBK
$43.6M
| $108K | ﹤0.01% |
133
-7
| -5% | -$2.26K |
|
|
MRSN
11210
CALL
DELISTED
Mersana Therapeutics
MRSN
| $108K | ﹤0.01% |
1,856
-3,484
| -65% | -$140K |
|
|
MREO
11211
CALL
Mereo BioPharma
MREO
$43.4M
| $107K | ﹤0.01% |
46,500
-55,300
| -54% | -$106K |
|
11212
Harvard Bioscience
HBIO
$36M
| $107K | ﹤0.01% |
+2,005
| New | +$90.5K |
|
|
PHLT
11213
DELISTED
Performant Healthcare Inc
PHLT
| $107K | ﹤0.01% |
34,314
+24,244
| +241% | +$63.5K |
|
|
AMRN
11214
PUT
Amarin Corp
AMRN
$297M
| $107K | ﹤0.01% |
6,155
-6,520
| -51% | -$102K |
|
|
BRW
11215
Saba Capital Income & Opportunities Fund
BRW
$329M
| $107K | ﹤0.01% |
+13,860
| New | +$106K |
|
11216
Citius Pharmaceuticals
CTXR
$17.3M
| $107K | ﹤0.01% |
5,640
+3,660
| +185% | +$69.4K |
|
|
ICD
11217
DELISTED
Independence Contract Drilling, Inc.
ICD
| $107K | ﹤0.01% |
43,498
-5,828
| -12% | -$15K |
|
11218
Scilex Holding
SCLX
$39.2M
| $107K | ﹤0.01% |
1,493
+78
| +6% | +$4.05K |
|
|
LUXH
11219
DELISTED
LuxUrban Hotels Inc. Common Stock
LUXH
| $106K | ﹤0.01% |
+255
| New | +$83.2K |
|
11220
PUT
Redwire
RDW
$2.82B
| $106K | ﹤0.01% |
37,300
-540,400
| -94% | -$1.48M |
|
11221
Seer Inc
SEER
$111M
| $106K | ﹤0.01% |
+54,789
| New | +$97.4K |
|
11222
PUT
IRIDEX
IRIX
$12.4M
| $106K | ﹤0.01% |
37,800
+7,600
| +25% | +$20K |
|
11223
PUT
ReposiTrak
TRAK
$144M
| $106K | ﹤0.01% |
+10,600
| New | +$104K |
|
|
MCHB
11224
PUT
Mechanics Bancorp
MCHB
$3.56B
| $106K | ﹤0.01% |
10,300
-44,000
| -81% | -$304K |
|
11225
Oramed Pharmaceuticals
ORMP
$212M
| $106K | ﹤0.01% |
45,916
+32,848
| +251% | +$70.2K |
|
Similar funds
Jeff Yass's Q4 2023 Portfolio in Review
As of Q4 2023, Jeff Yass held 13,823 positions worth $525B, up 9.3% from $481B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jeff Yass's Q4 2023 filing shows 1,903 new, 5,066 increased, 5,122 reduced and 1,577 closed positions. Its largest new stake was Vanguard Emerging Markets Government Bond ETF: 471,007 shares worth $30M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.28B.
By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, up from 91% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2023 buy was Vanguard Emerging Markets Government Bond ETF: 471,007 shares worth $30M.
- Jeff Yass added most to Alibaba in Q4 2023, an estimated $422M increase.
- Jeff Yass's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.28B.
- Jeff Yass fully exited VMware, Inc in Q4 2023, selling an estimated $313M.
- Jeff Yass's ten largest holdings make up 24% of its $525B portfolio in Q4 2023.
- Jeff Yass opened 1,903 new positions and closed 1,577 in Q4 2023.
- Jeff Yass's portfolio value rose 9.3% quarter-over-quarter to $525B.
Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.